amphenicol. We conclude that this enzyme preparation permits rapid clinical quantitation of chloramphenicol.
Additional Keyplwases drug eitIbkUcs
#{149}pediab'Ic.
chemistry . drug metaboiltes
Chioramphenicol is a potent, broad-spectrum antibiotic. Its use in newborn infants and older children with hepatic disease (1) is restricted because of the potential accumulation of toxic quantities, an accumulation resulting from poor or absent hepatic conjugation and occasionally from delayed excretion of the conjugate by the kidney (2) .
Recent changes in medical practice and antibiotic susceptibility of pathogenic bacteria suggest that chloramphenicol may be used with increasing frequency in infants and children in the future. Improvements in neonatal intensive care have resulted in increased survival but longer hospitalization; one persistent problem has been nosocomial infections, which currently are caused by bacteria that are often resistant to multiple antibiotics, but rarely chloramphenicol.
Chloramphenicol is currently recommended for initial therapy of life-threatening disease caused by Hemophilus influenzae, because the increasing prevalence of ampicillin-resistant strains (3) . Unfortunately, the pharmacokinetics of chlorainphenicol in infants and young children are incompletely defined, and thus guidelines for dosages are uncertain. In anticipation of developing needed pharmacologic data and therapeutic regimes, we have sought a more suitable assay for chloramphenicol.
Existing methods for quantitation of chioramphenicol utilize microbiological, chemical, or physical techniques. Microbiological methods depend on an indicator bacterium that is sensitive to chioramphenicol but resistant to other antibiotics that may be administered concomitantly (4) . Antibiotic quantitation is determined by the inhibition of growth of the test organism compared to standard dilutions of test antibiotic. This method is widely practiced and accepted due to relative accuracy, low cost, and simplicity. However, most methods require volumes of serum inconvenient for use in small infants, and up to 24 h for interpretation.
Furthermore, many test bacteria contain /3-glucuronidase, an enzyme ca-'pable of liberating free chloramphenicol from mono-or diglucuronide esters. Thus total chloraniphenicol compounds rather than the metabolically active, free chloramphenicol, may be quantitated in the microbiologic assays. Chemical assays require the extraction of chioramphenicol into an organic solvent; extraction of test fluid is followed by reduction and quantitation of the aromatic nitro moiety of chloramphenicol (5, 6) . Such methods require a volume of serum that can be extracted, a volume usually excessive for repeated sampling in infants. Furthermore, falsely high values often result due to the presence of other aromatic nitro compounds (7) . Physical methods, such as polarography and spectrophotometry, can be used, but they do not distinguish glucuronide conjugates from free antibiotic (8, 9) . Chromatographic methods, such as gas-liquid chromatography, do not distinguish between free and conjugated chloramphenicol because of the stringent conditions needed to volatilize the drug (10 
Materials
Escherichia coli W6771R5 (which will be supplied to interested readers on request) was a gift of Dr. Julian Davies, while strain AB 1932-1/JJ1 was previously described in this laboratory (16 Therefore our assay was modified such that an aliquot of the reaction mixture was allowed to adsorb onto micropore filters which were then washed in water, dried under a heat lamp, and quantitated for absorbed radioactivity in a Packard Model 3375 scintifiation spectrometer, using POP and POPOP3 in toluene as the scintillant. The radioisotopic assay was further modified for quantitation of CAT activity (assay B), and of chloramphenicol (assay C). Assay B was constructed by mixing of 0. 
Results

Bacterial Antibiotic Sensitivity
The parent test-strain, 
Bacterial Source of CAT
Previously reported R-factor-mediated CAT's have been intracellular enzymes. Our results with the mutant R5 plasmid differed significantly. Table 1 depicts the results of CAT assays on different sub-cellular preparations of E. coli W677/ HCm R5 and AB 1932-1/JJ1. With the former, the CAT specific activity was nearly threefold greater in the osmotic shock extract than in an extract of sonicated AB 1932-1/JJ1. With AB 1932-1/JJ1 the specific activity of CAT was similar in both types of preparations. The low -galactosidase activity in the shocked extracts contrasted to the extensive activity in the sonicates and attested to the minimal rupture of cells by the osmotic shock procedure.
Because of the ease of purifying proteins from osmotically shocked fluids, CAT was readily purified from W677/HCm R5 ( Table 2) . For kinetic studies, CAT was further purified by molecular sieving and ion-exchange chromatography (17, 22) . However, we found that the fluid from osmotic shock was 
Reaction Products
Previously reported CAT's produce equal molar ratios of mono-and diacetylchloramphenicol.
To determine the product(s) produced by W677IHCm R5, 62.5 zg of chlorasnphenicol was incubated with partly purified CAT (0.12 units by assay A, 0.71 Mgof protein). Aliquots were removed at intervals during the incubation, chromatographed (solvent systems A and B), and visualized with short-wavelength ultraviolet light. After 2 mm of incubation, a faint spot with an RF of 0.65 in A and 0.30 in B was evident; with longer incubation, this product was not evident. Throughout the incubation, the predominant product had an RF compatible with diacetylchloramphenicol (RF 0.85 in system A, 0.14 in B).
Products produced with ['4C]acetyl-coenzyme A (spec. acty. 86.91 cpm/pmol) by extracts of W677/HCm R5 and AB 1932-1/JJ1 were compared. After 60 mm of incubation, extracts of AB 1932-1/JJ1 produced two products identifiable by chromatography (RF 0.83 and 0.68-system A) while W677/HCm R5 yielded a single product (with an RF of 0.85). The ultraviolet-absorbing spots were scraped from the chromatographic plates, extracted with methanol, and their radioactivity and chloramphenicol was quantitated. The single product of W677/HCm R5 had an acetyl/chioramphenicol ratio of 1.85/1.0, while those of AB 1932-1/JJ1 were 1.88/1.0 (RF 0.83) and 1.05:1.0 (RF 0.68). Thus the predominant if not the only product of HCm R5 CAT, is diacetylchloramphenicoL We also examined the ability of a osmotic-shocked fluid from strain W677/HCm R5 to reduce the nitro moiety of chloramphenicol to the corresponding amine. No detectable reduced chloramphenicol was formed, indicating that a third potential acetyl acceptor, an arylamine, is not formed under conditions of the assay.
CAT Substrate
Chloramphenicol hemisuccinate, the intravenous dosage form of the drug, was not acetylated by the partly purified CAT when added to chloramphenicol in concentrations equal to and 10-fold greater than unesterified drug (Table 3 ). To test for the possibility that these results were an artifact of the assay system-i.e., chloramphenicol-3-succinate can be acetylated but the potential product, 1-hydroxylacetyl-3-succinyl, is not bound to the micropore filter-we performed parallel assays: 1.55 nmol of chloramphenicol or chloramphenicol succinate was incubated with 0.045 units (spectrophotometric) of CAT (9.02 Mgof osmotically shocked protein) at 35 #{176}C in tris(hydroxyinethyl)methylamine buffer (50 mmol/liter, pH 7.8). Aliquots of these reaction mixtures were applied to filters or extracted three times with 1 ml of alkaline benzene. Chloramphenicol hemisuccinate was not acetylated by CAT in either assay method. Thus, the 1-hydroxy group of chloramphenicol-3-succinate does not appear to be acetylated by CAT osmotic-shocked preparations. Other chloramphenicol analogs were tested for substrate activity. Table 4 summarizes the Km of CAT partly purified from W677/HCm R5 as determined in assay B.
Recovery of Acetylated Chloramphenicol on Micropore Filters
We determjned the relative recovery of acetylated chloramphenicol by benzene extraction and micropore filter binding and the load capacities of filters for this product. Aliquots of a benzene extraction of a CAT reaction mixture (assay C) were pipetted onto micropore filters, which were washed and counted as described. As can be seen in Figure 1 , the amount of acetylated chloramphenicol recovered in henzene exceeded that bound to filters; however, the concentration of benzene-extractable product bound to filters was proportional to that applied (the highest concentration tested was 50 mg/liter). The reproducibility of benzene extraction and filter binding were similar at low concentrations of chloramphenicol (5-15 mg/liter); however, at concentrations of 25-50 mg/liter, there was more variability in recovery by benzene extraction. 
ed.
Before utilizing the radioenzymatic assay for clinical quantitation of chloramphenicol, we determined the effect of pH, ionic strength, and pore size of filters on the binding of acetylch.loramphenicol by micropore filters. Our data (Table 5) indicate that the amount of radiolabeled chloraniphenicol acetate was not significantly affected by washes of pH 4.0-9.0. The smaller-pore-size filter absorbed more acetylchloramphenicol than larger-pore filters at all pH values tested; however, the lowest blank value was obtained at pH 7.0. Because the 0.l5-Mm filter, with washing at pH 7.0, produced the lowest blanks with maximum binding capacity, it was used for clinical assays. Tables 6 and 7 depict that no tested antibiotic or compounds commonly added to clinical specimens of blood adversely affected the enzymatic quantitation of 2 or 10 mg of chloramphenicol per liter. 
Quantitation of Chloramphenicol
#{149}
The incubation of chloramphenicol glucuronide with -glucuronidase produced an increasing amount of product, which was acetylated by an osmotically shocked preparation of CAT (Table 8) .
#{149} On 24-h incubation with -glucuronidase half of the total chloramphenicol (determined colorimetrically) was acetylated.
#{149} Table 9 depicts the -glucuronidase activity present in certain fractions of strains W677/HCm R5 and AB 1932-1/JJ1. As can be seen, the osmotic-shocked material from W677/ 0.26 unIt, was added to 18.6 mg of chloramphenlcol giucuronlde In a total volume of 7.0 (pH 4.5. acetate 10 mmol/l) and themixture was incubated at 35 #{176}C; aliquots were removed at the times Indicated and chioramphenicol assayed with CAT (assayC). Five microliters of antibiotic stocks was added to 0.5 ml of serum containing chioramphenicol at 2 or 10 mg/lIter. The sara were mixed and the chioramphenlcol quantitated with assay C, with use of 0.15-Mm filters and a wash pH of 7.0. The apparent inhibition seenat the higher heparin concentration was reversed by adjusting the heparin solution to pH 7.5 before addingIt toblood containing chioramphenicoi. Chioramphenicol was assayed by method C, with useof 0.15 m filters and a wash pH of 7.0. 
Discussion
These studies were initiated to determine the feasibility of an enzymic method for quantitating chloramphenicol, utilizing an R-factor-mediated chioramphenicol acetyltransferase (CAT). In the course of these experiments, the enzyme produced by plasmid R5 was found to be similar to previously described CAT's with respect to substrate specificity and pH optimum.
However the R5 CAT is uniquely released from bacteria by osmotic shock (17) , and synthesizes primarily, if not solely, diacetylchloramphenicol.
Further studies are needed to define more completely the biochemical and genetic differences in the CAT's produced by Enterobacteriaceae. The periplasmic localization of the R5 CAT greatly facilitates its purification.
We were able to purify the enzyme 159-fold by conventional methods (17, 22) . We, like others (24), were unable to purify CAT activity by affinity chromatography.
The The accuracy, specificity, and convenience of this assay system suggest it is as an improvement over existing microbiologic, physical, or chemical methods for quantitation of chloramphenicol.
It is anticipated that it will facilitate needed studies of the pharmacokinetics of chloraxnphenicol, particularly in infants and ill children.
